History

Patients present for care of ingrown nails due to discomfort. Ingrown nails may cause significant pain. If a toenail is involved, the discomfort worsens with weightbearing and ambulation. The patient with an ingrown nail presents with a sharp, focal pain adjacent to the nail bed of the affected digit. The patient or parents may typically describe crusting, purulence, and friable granulation tissue at the site.

Physical Examination

Upon examination, the following may be present:

Edema or inflammation of tissue surrounding the nail bed
Erythema of the same tissue
Macerated or friable granulation tissue
Crusting
Drainage
Hypertrophy of the nail margin
Hypertrophy of the surrounding epidermis

Accordingly, ingrown nail has been divided into the following three stages^[20]:

Stage 1: Mild erythema edema and pain with pressure
Stage 2: Significant erythema, edema, local infection, and discharge
Stage 3: Granulation tissue formation and hypertrophy of the lateral wall besides the significant erythema, edema, and discharge (see image below)

Stage 3 ingrown nail. Courtesy of Wikimedia Commons.
View Media Gallery

Complications

Development of paronychia is the most common complication. If paronychia is not treated, the condition may progress to cellulitis, osteomyelitis, or systemic infection.

If neglected, abscess formation (paronychia) can spread and lead to osteomyelitis, systemic infection, and sepsis; amputation of the digit may even be required for definitive treatment.

An ingrown nail causes varying degrees of inflammation in the surrounding tissue, and this may predispose to infection if not well treated.

Hypertrophy of the medial and lateral skin folds may occur, as shown in the image below, and bilateral sidewall hypertrophy that covers the entire nail has been reported.^[21]

Hypertrophy of the lateral nail fold that partially cover the nail. Courtesy of Dermatology Research and Practice (Haneke, E. "Controversies in the Treatment of Ingrown Nails." Dermatology Research and Practice. 2012; 2012:783924).

View Media Gallery

Pyogenic granuloma may develop on longstanding infected ingrown nails.

If left untreated, chronic inflammation may cause skin bridging secondary to epithelialization of the adjacent inflamed hypertrophied soft tissue.^[22]

Keloid formation may result from chronic inflammation, especially in cases of recurrent ingrown nails.^[23]

Recurrence is defined as the occurrence of pain, discomfort, erythema, and/or drainage at the site of the treated nail edge.

Although infrequent, postsurgical infection may occur in a small percentage of patients. Appropriate precautions should be given to return for any signs of infection or fever.

Differential Diagnoses

Zaraa I, Kort R, Mokni M, Ben Osman A. Retronychia: a rare cause of chronic paronychia. Dermatol Online J. 2012 Jun 15. 18(6):9. [Medline].
Tatlican S, Yamangöktürk B, Eren C, Eskioglu F, Adiyaman S. [Comparison of phenol applications of different durations for the cauterization of the germinal matrix: an efficacy and safety study]. Acta Orthop Traumatol Turc. 2009 Aug-Oct. 43(4):298-302. [Medline].
Martinez-Nova A, Sanchez-Rodriguez R, Alonso-Pena D. A new onychocryptosis classification and treatment plan. J Am Podiatr Med Assoc. 2007 Sep-Oct. 97(5):389-93. [Medline].
Haneke E. Controversies in the treatment of ingrown nails. Dermatol Res Pract. 2012. 2012:783924. [Medline]. [Full Text].
Langford DT, Burke C, Robertson K. Risk factors in onychocryptosis. Br J Surg. 1989 Jan. 76(1):45-8. [Medline].
Luther J, Glesby MJ. Dermatologic adverse effects of antiretroviral therapy: recognition and management. Am J Clin Dermatol. 2007. 8(4):221-33. [Medline].
Baran R. Retinoids and the nails. J Dermatol Treat. 1990. 1:151-4.
Nicolopoulos J, Howard A. Docetaxel-induced nail dystrophy. Australas J Dermatol. 2002 Nov. 43(4):293-6. [Medline].
Higgins EM, Hughes JR, Snowden S, Pembroke AC. Cyclosporin-induced periungual granulation tissue. Br J Dermatol. 1995 May. 132(5):829-30. [Medline].
Erdogan FG, Tufan A, Guven M, Goker B, Gurler A. Association of hypermobility and ingrown nails. Clin Rheumatol. 2012 Sep. 31(9):1319-22. [Medline].
Córdoba-Fernández A, Montaño-Jiménez P, Coheña-Jiménez M. Relationship between the presence of abnormal hallux interphalangeal angle and risk of ingrown hallux nail: a case control study. BMC Musculoskelet Disord. 2015 Oct 15. 16:301. [Medline].
Wang CY, Hong CC, Su TF, Chang SC. Paronychia with Sporangium Formation Causing an Ingrown Toenail A Rare Case Report. J Am Podiatr Med Assoc. 2017 Nov 8. [Medline].
Ezekian B, Englum BR, Gilmore BF, Kim J, Leraas HJ, Driscoll TA, et al. Children Receiving Hematopoietic Stem Cell Transplantation are at Increased Risk of Onychocryptosis Requiring Surgical Management. J Pediatr Hematol Oncol. 2017 Oct. 39 (7):e353-e356. [Medline].
Pico AM, Verjano E, Mayordomo R. Relation Between Nail Consistency and Incidence of Ingrown Toenails in Young Male Runners. J Am Podiatr Med Assoc. 2017 Mar. 107 (2):137-143. [Medline].
Vural S, Bostanci S, Koçyigit P, Çaliskan D, Baskal N, Aydin N. Risk Factors and Frequency of Ingrown Nails in Adult Diabetic Patients. J Foot Ankle Surg. 2018 Mar - Apr. 57 (2):289-295. [Medline].
Cho SY, Kim YC, Choi JW. Epidemiology and bone-related comorbidities of ingrown nail: A nationwide population-based study. J Dermatol. 2018 Dec. 45 (12):1418-1424. [Medline].
Grassbaugh JA, Mosca VS. Congenital ingrown toenail of the hallux. J Pediatr Orthop. 2007 Dec. 27(8):886-9. [Medline].
Lee JH, Kim SE, Park K, Son SJ. Congenital ingrown toenails successfully treated with simple plastic tube insertion. Int J Dermatol. 2008 Feb. 47(2):209-10. [Medline].
Sarifakioglu E, Yilmaz AE, Gorpelioglu C. Nail alterations in 250 infant patients: a clinical study. J Eur Acad Dermatol Venereol. 2008 Jun. 22(6):741-4. [Medline].
Ozdemir E, Bostanci S, Ekmekci P, Gurgey E. Chemical matricectomy with 10% sodium hydroxide for the treatment of ingrowing toenails. Dermatol Surg. 2004 Jan. 30(1):26-31. [Medline].
Seyfettinoglu F, Sünneli Ö, Dülgeroglu A, Bora OA. A case of ingrown toenail accompanied by extreme soft tissue hypertrophy to the extent of invisible nail. Acta Orthop Traumatol Turc. 2012. 46(5):407-10. [Medline].
Dadaci M, Ince B, Altuntas Z, Kamburoglu HO, Bitik O. Skin bridging secondary to ingrown toenail. Pak J Med Sci. 2014 Nov-Dec. 30 (6):1425-7. [Medline].
Lee KW, Burm JS, Yang WY. Keloid formation on the great toe after chronic paronychia secondary to ingrown nail. Int Wound J. 2013 Apr. 10(2):200-2. [Medline].
Senapati A. Conservative outpatient management of ingrowing toenails. J R Soc Med. 1986 Jun. 79(6):339-40. [Medline]. [Full Text].
Manca D. Practice tips. Taping toes. Effective treatment for ingrown toenails. Can Fam Physician. 1998 Feb. 44:275. [Medline]. [Full Text].
Wallace WA, Milne DD, Andrew T. Gutter treatment for ingrowing toenails. Br Med J. 1979 Jul 21. 2(6183):168-71. [Medline]. [Full Text].
Watabe A, Yamasaki K, Hashimoto A, Aiba S. Retrospective evaluation of conservative treatment for 140 ingrown toenails with a novel taping procedure. Acta Derm Venereol. 2015 Sep. 95 (7):822-5. [Medline].
Ozdil B, Eray IC. New method alternative to surgery for ingrown nail: angle correction technique. Dermatol Surg. 2009 Jun. 35(6):990-2. [Medline].
Woo SH, Kim IH. Surgical pearl: nail edge separation with dental floss for ingrown toenails. J Am Acad Dermatol. 2004 Jun. 50(6):939-40. [Medline].
Moriue T, Yoneda K, Moriue J, Matsuoka Y, Nakai K, Yokoi I, et al. A simple therapeutic strategy with super elastic wire for ingrown toenails. Dermatol Surg. 2008 Dec. 34(12):1729-32. [Medline].
Erdogan FG, Erdogan G. Long-term results of nail brace application in diabetic patients with ingrown nails. Dermatol Surg. 2008 Jan. 34(1):84-6; discussion 86-7. [Medline].
Ince B, Dadaci M, Altuntas Z. Knot technique: a new treatment of ingrown nails. Dermatol Surg. 2015 Feb. 41 (2):250-4. [Medline].
Nishioka K, Katayama I, Kobayashi Y, Takijiri C, Nishioka K. Taping for embedded toenails. Br J Dermatol. 1985 Aug. 113 (2):246-7. [Medline].
Arai H, Arai T, Nakajima H, Haneke E. Formable acrylic treatment for ingrowing nail with gutter splint and sculptured nail. Int J Dermatol. 2004 Oct. 43(10):759-65. [Medline].
Ozan F, Dogar F, Altay T, Ugur SG, Koyuncu S. Partial matricectomy with curettage and electrocautery: a comparison of two surgical methods in the treatment of ingrown toenails. Dermatol Surg. 2014 Oct. 40(10):1132-9. [Medline].
Livingston MH, Coriolano K, Jones SA. Nonrandomized assessment of ingrown toenails treated with excision of skinfold rather than toenail (NAILTEST): An observational study of the Vandenbos procedure. J Pediatr Surg. 2017 May. 52 (5):832-836. [Medline].
Issa MM, Tanner WA. Approach to ingrowing toenails: the wedge resection/segmental phenolization combination treatment. Br J Surg. 1988 Feb. 75(2):181-3. [Medline].
Tatlican S, Yamangöktürk B, Eren C, Eskioglu F, Adiyaman S. [Comparison of phenol applications of different durations for the cauterization of the germinal matrix: an efficacy and safety study]. Acta Orthop Traumatol Turc. 2009 Aug-Oct. 43(4):298-302. [Medline].
Barreiro KN, Moradi M, Merrill T, Losito J, Southerland C, Buckley B. Healing efficacy and participant outcomes of chemical matrixectomies using a hydrogel containing oakin. J Am Podiatr Med Assoc. 2014 Nov. 104 (6):617-21. [Medline].
Bostanci S, Kocyigit P, Gürgey E. Comparison of phenol and sodium hydroxide chemical matricectomies for the treatment of ingrowing toenails. Dermatol Surg. 2007 Jun. 33(6):680-5. [Medline].
Bostancı S, Koçyiğit P, Güngör HK, Parlak N. Complications of sodium hydroxide chemical matrixectomy: nail dystrophy, allodynia, hyperalgesia. J Am Podiatr Med Assoc. 2014 Nov. 104 (6):649-51. [Medline].
Terzi E, Guvenc U, Türsen B, Kaya TI, Erdem T, Türsen Ü. The effectiveness of matrix cauterization with trichloroacetic acid in the treatment of ingrown toenails. Indian Dermatol Online J. 2015 Jan-Feb. 6(1):4-8. [Medline]. [Full Text].
Kim SH, Ko HC, Oh CK, Kwon KS, Kim MB. Trichloroacetic acid matricectomy in the treatment of ingrowing toenails. Dermatol Surg. 2009 Jun. 35 (6):973-9. [Medline].
Barreiros H, Matos D, Goulão J, Serrano P, João A, Brandão FM. Using 80% trichloroacetic acid in the treatment of ingrown toenails. An Bras Dermatol. 2013 Nov-Dec. 88 (6):889-93. [Medline].
Ozawa T, Nose K, Harada T, Muraoka M, Ishii M. Partial matricectomy with a CO2 laser for ingrown toenail after nail matrix staining. Dermatol Surg. 2005 Mar. 31(3):302-5. [Medline].
Ali SM, Ahmed GS, Tahir SM. Outcome of partial nail plate and matrix removal (Winograd technique) for ingrown toe nail. J Liaquat Uni Med Health Sci. 2013. 12:182-5.
Kim M, Song IG, Kim HJ. Partial Removal of Nail Matrix in the Treatment of Ingrown Nails: Prospective Randomized Control Study Between Curettage and Electrocauterization. Int J Low Extrem Wounds. 2014 Sep 25. [Medline].
Akkus A, Demirseren DD, Demirseren ME, Aktas A. The treatment of ingrown nail: Chemical matricectomy with NAOH versus wedge resection. Dermatol Ther. 2018 Sep. 31 (5):e12677. [Medline].
André MS, Caucanas M, André J, Richert B. Treatment of Ingrowing Toenails With Phenol 88% or Trichloroacetic Acid 100%: A Comparative, Prospective, Randomized, Double-Blind Study. Dermatol Surg. 2018 May. 44 (5):645-650. [Medline].
Córdoba-Fernández A, Rodríguez-Delgado FJ. Anaesthetic digital block with epinephrine vs. tourniquet in ingrown toenail surgery: a clinical trial on efficacy. J Eur Acad Dermatol Venereol. 2014 Oct 3. [Medline].

Media Gallery

Right great toe paronychia in a 3-year-old child. Courtesy of Ann G. Egland, MD.
Preparing for digital block before surgical treatment of paronychia of right great toe. Universal precautions should always be observed. Courtesy of Ann G Egland, MD.
Neonatal ingrown nail. Courtesy of Dermatology Research and Practice (Haneke, E. "Controversies in the Treatment of Ingrown Nails." Dermatology Research and Practice. 2012; 2012:783924).
Pincer nail. Courtesy of Dermatology Research and Practice (Haneke, E. "Controversies in the Treatment of Ingrown Nails." Dermatology Research and Practice. 2012; 2012:783924).
Stage 3 ingrown nail. Courtesy of Wikimedia Commons.
Schematic view for cotton wick insertion. Courtesy of Dermatology Research and Practice (Haneke, E. "Controversies in the Treatment of Ingrown Nails." Dermatology Research and Practice. 2012; 2012:783924).
Schematic view illustrating taping of the nail. Courtesy of Dermatology Research and Practice (Haneke, E. "Controversies in the Treatment of Ingrown Nails." Dermatology Research and Practice. 2012; 2012:783924).
Schematic view illustrating gutter technique. Courtesy of Dermatology Research and Practice (Haneke, E. "Controversies in the Treatment of Ingrown Nails." Dermatology Research and Practice. 2012; 2012:783924).
Hypertrophy of the lateral nail fold that partially cover the nail. Courtesy of Dermatology Research and Practice (Haneke, E. "Controversies in the Treatment of Ingrown Nails." Dermatology Research and Practice. 2012; 2012:783924).

of 9

Author

Amira M Elbendary, MBBCh, MSc Visiting Dermatopathology Fellow, Ackerman Academy of Dermatopathology; Assistant Lecturer, Department of Dermatology, Kasr Alainy University Hospitals, Cairo University, Egypt

Amira M Elbendary, MBBCh, MSc is a member of the following medical societies: Bloom’s Syndrome Association, Egyptian Medical Syndicate, International Dermoscopy Society, Medical Dermatology Society

Disclosure: Nothing to disclose.

Coauthor(s)

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Chief Editor

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD<br/>Served as a speaker for various universities, dermatology societies, and dermatology departments.

Additional Contributors

Kevin P Connelly, DO Clinical Assistant Professor, Department of Pediatrics, Division of General Pediatrics and Emergency Care, Virginia Commonwealth University School of Medicine; Medical Director, Paws for Health Pet Visitation Program of the Richmond SPCA; Pediatric Emergency Physician, Emergency Consultants Inc, Chippenham Medical Center

Kevin P Connelly, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Osteopathic Pediatricians, American Osteopathic Association

Disclosure: Nothing to disclose.

Acknowledgements

Thomas Craig, MD Resident Physician, Department of Emergency Medicine, Naval Medical Center

Disclosure: Nothing to disclose.

Ann G Egland, MD Consulting Staff, Department of Operational and Emergency Medicine, Walter Reed Army Medical Center

Ann G Egland, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Association of Military Surgeons of the US, Medical Society of Virginia, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.